Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (641-650 of 737) with videos related to

Pageof 74
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 29, 2012
Space environment of an asteroid preserved on micrograins returned by the Hayabusa spacecraftEizo Nakamura, Akio Makishima, Takuya Moriguti, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full AgonistsHiroki Kakuta, Nobumasa Yakushiji, Ryosuke Shinozaki, et al.
Journal of Medicinal Chemistry|February 9, 2013
Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potencyFuminori Ohsawa, Shoya Yamada, Nobumasa Yakushiji, et al.
Science (New York, N.Y.)|October 23, 1992
The yohkoh mission for high-energy solar physicsL Acton, M Bruner, J Lemen, et al.
Cell Reports|September 10, 2014
Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene networkJing Fang, Brenden Barker, Lyndsey Bolanos, et al.
Leukemia|October 18, 2012
Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiencyL Yang, A Mailloux, D E Rollison, et al.
Oncotarget|February 5, 2019
Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinomaGoro Kasuya, Hiroshi Tsuji, Takuma Nomiya, et al.
Cancer Science|July 8, 2018
Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinomaGoro Kasuya, Hiroshi Tsuji, Takuma Nomiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
<i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant InhibitorsRemco J Molenaar, Tomas Radivoyevitch, Yasunobu Nagata, et al.
BMC Oral Health|January 24, 2025
Histopathology of the tongue in a hamster model of COVID-19John Coggins, Marina Hosotani Saito, Rebecca Cook, et al.
Pageof 74

Showing results (641-650 of 737) with videos related to

Sort By:
Pageof 74
Proceedings of the National Academy of Sciences of the United States of America|February 29, 2012
Space environment of an asteroid preserved on micrograins returned by the Hayabusa spacecraftEizo Nakamura, Akio Makishima, Takuya Moriguti, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full AgonistsHiroki Kakuta, Nobumasa Yakushiji, Ryosuke Shinozaki, et al.
Journal of Medicinal Chemistry|February 9, 2013
Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potencyFuminori Ohsawa, Shoya Yamada, Nobumasa Yakushiji, et al.
Science (New York, N.Y.)|October 23, 1992
The yohkoh mission for high-energy solar physicsL Acton, M Bruner, J Lemen, et al.
Cell Reports|September 10, 2014
Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene networkJing Fang, Brenden Barker, Lyndsey Bolanos, et al.
Leukemia|October 18, 2012
Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiencyL Yang, A Mailloux, D E Rollison, et al.
Oncotarget|February 5, 2019
Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinomaGoro Kasuya, Hiroshi Tsuji, Takuma Nomiya, et al.
Cancer Science|July 8, 2018
Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinomaGoro Kasuya, Hiroshi Tsuji, Takuma Nomiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
<i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant InhibitorsRemco J Molenaar, Tomas Radivoyevitch, Yasunobu Nagata, et al.
BMC Oral Health|January 24, 2025
Histopathology of the tongue in a hamster model of COVID-19John Coggins, Marina Hosotani Saito, Rebecca Cook, et al.
Pageof 74